PepIVAC-01

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePepIVAC-01
Drug Alias Namepeptide vaccine (Eberhard-Karls-University of Tubingen/Istituto Nazionale Tumori)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEberhard Karls University Tübingen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFondazione Irccs Istituto Nazionale Dei TumoriEberhard Karls University Tübingen
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A